Dolutegravir, Abacavir and Lamivudine ( DrugBank: Lamivudine, Abacavir, Dolutegravir )


1 disease
告示番号疾患名(ページ内リンク)臨床試験数
2筋萎縮性側索硬化症1

2. 筋萎縮性側索硬化症


臨床試験数 : 645 薬物数 : 589 - (DrugBank : 163) / 標的遺伝子数 : 150 - 標的パスウェイ数 : 225
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT05193994
(ClinicalTrials.gov)
February 24, 20226/12/2021Triumeq in Amyotrophic Lateral SclerosisRandomised Double-Blind Placebo-Controlled Phase 3 Trial of Triumeq in Amyotrophic Lateral SclerosisAmyotrophic Lateral SclerosisDrug: Dolutegravir, Abacavir and Lamivudine;Drug: PlaceboMacquarie University, AustraliaKing's College London;Stichting TRICALS FoundationRecruiting18 YearsN/AAll390Phase 3Australia